Pharmacokinetics, metabolism, bioavailability, tissue distribution and excretion studies of 16α-hydroxycleroda-3, 13(14) Z -dien-15, 16-olide—a novel HMG-CoA reductase inhibitor-Reference-Cited by-同舟云学术

Pharmacokinetics, metabolism, bioavailability, tissue distribution and excretion studies of 16α-hydroxycleroda-3, 13(14) Z -dien-15, 16-olide—a novel HMG-CoA reductase inhibitor

Published:2018-06-06 Issue:9 Volume:391 Page:965-973
ISSN:0028-1298
Container-title:Naunyn-Schmiedeberg's Archives of Pharmacology
language:en
Short-container-title:Naunyn-Schmiedeberg's Arch Pharmacol

Author:

Laxman Tulsankar Sachin,Puttrevu Santosh Kumar,Pradhan Rajesh,Mishra Anjali,Verma Sarvesh,Chhonker Yashpal S.,Srivastava Swarnim,Singh Suriya P.,Sashidhara Koneni V.,Bhatta Rabi Sankar

Funder

THUNDER

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,General Medicine

Link

http://link.springer.com/article/10.1007/s00210-018-1518-0/fulltext.html

Reference20 articles.

1. Bhatta R, Kumar D, Chhonker Y, Kumar D, Singh SP, Sashidhara KV, Jain G (2012) Simultaneous estimation of 16α-hydroxycleroda-3, 13 (14) Z-dien-15, 16-olide from Polyalthia longifolia and its metabolite in hamster plasma: application to pharmacokinetic study. Biomed Chromatogr 26:559–565

2. Brown RP, Delp MD, Lindstedt SL, Rhomberg LR, Beliles RP (1997) Physiological parameter values for physiologically based pharmacokinetic models. Toxicol Ind Health 13:407–484

3. Casey Laizure S, Herring V, Hu Z, Witbrodt K, Parker RB (2013) The role of human carboxylesterases in drug metabolism: have we overlooked their importance? Pharmacother: J Human Pharmacol Drug Ther 33:210–222